Home About Us 2003 Innovators Past Innovators Facts About Substance Abuse Press/Events FAQs Contacts Us
Innovators

Since 2000, twenty individuals have received the Innovators Award in recognition of their pioneering contributions to reduce substance abuse and drug addiction. Their work has expanded the science of addiction; laid the foundation for improved prevention and treatment; advanced policy; and broken new ground in communication and educational strategies. The following pages will introduce you to these remarkable people who have devoted their lives to substance abuse control.

Please click an Innovator's name below to view details regarding their Award and other accomplishments.

Innovator Award Recipients in 2003

Michael C. Fiore, MD, MPH has led efforts to make tobacco use one of the basic vital signs assessed by physicians. He chaired the federal subcommittee that developed the internationally used Clinical Practice Guidelines to treat tobacco addiction of the US Public Health Service.  Dr. Fiore is using his Innovator Award to help implement key components of the widely acclaimed National Action Plan for Tobacco Cessation that has the potential to prevent 3 million premature deaths annually among current smokers, and to save millions more lives over the longer term.    

Raymond Materson is a needlepoint artist whose nationally exhibited work, which provides powerful and compelling portrayals of addiction from its penetration into every day life, its horrors, and the triumph of recovery, has been widely acclaimed by art critics, addiction experts, and addicted people. Mr. Materson is using his Innovator Award to develop an artist in residence program in substance abuse for adolescents in an effort to foster a national corp of artists who can show the human side of addiction, and thereby provide the groundwork for expansion of the treatment and prevention programs necessary to improve our nation’s health.

A. Thomas McLellan, PhD pioneered the objective assessment of addiction through the internationally used Addiction Severity Index and has lead efforts to help determine what works and what doesn’t in treatment. Dr. McLellan is using his Innovator Award to identify the factors that show promise in revolutionizing treatment delivery and producing major advances in helping addicted persons achieve and sustain abstinence and improved health.

William R. Miller, PhD is a scientist/clinician who radically changed the way health professionals conceptualize and deliver treatment though an approach that is called “motivational interviewing,” which has been seamlessly assimulated into many modes of treatment.  Dr. Miller is using his Innovator Award in a forward looking project intended to evaluate treatment from the perspective of where our nation’s health care approaches toward treatment should be headed in decades to come, including how today’s potential “fringe” treatments might fit in the ideal 21st century system.

Mark Parrino, MPA is recognized as one of the nation’s most dedicated, creative, and effective forces promoting the appropriate use of pharmacotherapy for the treatment of heroin and other addictive opioid drugs.  Mr. Parrino is using his Innovator Award to develop and implement creative ways to treat thousands of incarcerated persons afflicted with opioid addiction to improve their ability to re-enter mainstream America as healthy contributing citizens upon their release.

Innovator Award Recipients in 2002

Carlo C. DiClemente, PhD is internationally recognized (in partnership with Innovator Dr. James Prochaska) for his work on how drug addicted people change in their interest and ability to achieve abstinence. This work on “stages of change” has emerged as the bedrock of many treatment programs. Dr. DiClemente uses his Innovator Award to evaluate critical predictors of recovery from substance abuse so that these can be incorporated into drug addiction treatment and thereby enable even the most die-hard substance abusers to achieve and sustain abstinence.

Larry M. Gentilello, MD, FACS published key studies documenting the extraordinarily high contribution of drug and alcohol abuse to life-threatening injury and the potentially powerful impact of hospital-based trauma center interventions to reduce such problems.  Dr. Gentilello uses his Innovator Award to develop the science base on alcohol- and drug-related trauma and disseminates the findings to policy makers who have the potential to remove the current institutional barriers to widespread application of these proven life-saving approaches.

James O. Prochaska, PhD has been recognized (in partnership with Innovator Dr. Carlo DiClemente) for his work on how drug addicted people change in their interest and ability to achieve abstinence. This work on “stages of change” has emerged as the bedrock of many treatment programs. Dr. Prochaska is using his Innovator Award to further develop promising but novel approaches to prevent and treat alcohol and tobacco abuse among adolescents and young adults.

James L. Repace, MSc led the efforts of the Environmental Protection Agency and the Surgeon General that developed the science base for understanding the extreme toxicity of environmental smoke, and the effectiveness of various potential options for protecting people and reducing disease caused by this category of air-born toxins.  Mr. Repace uses his Innovator Award to conduct scientific studies of the impact of various potential solutions to reduce tobacco smoke exposure in hospitality venues such as restaurants, bars, and nightclubs. His evidence-based work provides the foundation for policies to reduce exposure and disease among employees as well as patrons who visit these establishments.

Paul N. Samuels, JD has been a leading legal advocate for sensible national and state policies aimed at reducing drug and alcohol abuse by ensuring fair and equitable treatment of addicted persons through the Legal Action Center, which is located in New York City. Mr. Samuels uses his Innovator Award to evaluate and communicate the critical “behind-the-scenes” legal and policy issues, which can either facilitate or serve as barriers to substance abuse treatment.

Innovator Award Recipients in 2001

Julia Carol is a nationally recognized leader in the nonsmokers’ rights movements.  She has developed strategies to reduce exposure of nonsmokers, children and workers to environmental tobacco smoke.  Ms. Carol used her Innovator Award to expand the Tobacco Industry Tracking Database, making it available on the world wide web to the global community of advocates, health professionals and the media. The database assists their efforts to expose and counter tobacco industry interference with public health efforts.

Gary A. Giovino, PhD led the Center for Disease Control’s epidemiological efforts to help unravel key questions such as determining the number of tobacco users who are actually addicted; the development of addiction among adolescents; and potential differences in the success rates of smoking cessation among men and women. Dr. Giovino uses his Innovator Award to enhance the nation’s tobacco surveillance system by addressing how potential new tobacco products might contribute to overall tobacco use and tobacco-caused disease and death.

Ralph W. Hingson, ScD is an internationally recognized leader on the science of drunk driving prevention. His studies provided the scientific foundation for policy changes that have prevented hundreds of thousands of drunk driving accidents, by enabling organizations such as Mothers Against Drunk Driving (MADD) to educate policy makers on these issues.  Dr. Hingson uses his Innovator Award to develop novel strategies to reduce alcohol use, injury, and other harmful consequences of drinking among youth, and to prevent the transition from alcohol exposure early in life to heavy drinking and associated injury during the adult years.

G. Alan Marlatt, PhD is a pioneer who explored factors that led most alcohol- and drug-addicted persons to relapse within weeks of their sobriety. His concepts are embodied in most addiction treatment programs that are designed to sustain long-term abstinence.  Dr. Marlatt uses his Innovator Award to extend his findings on prevention and relapse in reservation-based Native American youth, and to assess the efficacy of novel approaches to treatment and relapse prevention, such as using meditation.

Alexander C. Wagenaar, PhD has conducted internationally recognized research on converging factors that either foster or reduce substance abuse, including drinking and driving fatalities among young drivers.  Dr. Wagenaar uses his Innovator Award to compare and contrast the potential application of legal strategies to reduce injury and death caused by tobacco, as well as inappropriate uses of alcohol and firearms.

Innovator Award Recipients in 2000

Stanton A. Glantz, PhD has been recognized as a stalwart leader with a unique ability to effectively frame issues related to tobacco control. He is fearless in his willingness to stand-up to the tobacco industry. Dr. Glantz used his Innovator Award to expand his world-wide acclaimed efforts to unveil the role of the film and television industry in the promotion of tobacco use.

Sandra W. Headen, PhD is one of the leaders in the tobacco prevention field whose work has been acknowledged for its understanding and implementation of culturallyspecific tobacco use prevention programs for African-Americans. Dr. Headen used her Innovator Award to tailor tobacco use prevention programs to African-American Youth by refining the Ujima! African-American Youth Initiative.

Jack E. Henningfield, PhD is recognized for his scientific contributions in establishing that nicotine is an addictive drug and that tobacco use is strongly driven by nicotine addiction.  Dr. Henningfield used his Innovator Award to establish a more systematic approach to bring relevant tobacco addiction science to the attention of policy makers.

Dr. Henningfield consults to private and nonprofit organizations on addiction control, risk management and other issues at the intersection of science, health and policy, through Pinney Associates (see www.pinneyassociates.com).

Denise A. Herd, PhD is widely recognized for her work on African-American, Latino, and other communities’ drinking patterns and problems. It has been a critical component of the broader shift in the alcohol field from viewing problems as primarily a manifestation of individual deviance to a focus on more complex, systemic issues of the broader environment. Dr. Herd is using her Innovator Award to evaluate substance abuse policy education and interventions regarding alcohol, illegal drugs and violence, and the potential for media such as rap music to either foster or reduce such problems.

Lawrence Wallack, DrPH is known for his pioneering efforts on “media advocacy,” which involves the broad range of media to change the conditions at the community level that have the potential to counter the social conditions that foster substance abuse.  Dr. Wallack is using his Innovator Award to test drug abuse prevention media messages, and to develop a strategic framework for community-based prevention programs.  This will allow a much broader application of such approaches to address our nation’s substance abuse related problems.

Copyright 2004 The Johns Hopkins University. Baltimore, Maryland.
All rights reserved. Last Updated January 15, 2010
 

About Us  |  The Innovators  |  Other Resources  |  Facts About Substance Abuse  |  Press/Events
Contact Us  |  FAQs  |  Home